for March 2019
NEW 🔥🔥🔥in CID
— Antibiotic Steward (@ABsteward) March 21, 2019
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America. @IDSAInfo https://t.co/QgpfLCpqjW pic.twitter.com/41tXqqCVNM
Just released 🔥🔥🔥
— Antibiotic Steward (@ABsteward) March 6, 2019
Infectious Diseases & Antimicrobial Stewardship Journal Articles Hot Off The Press In February 2019, A monthly post by @IDstewardship
And I. #antibioticsteward #IDTwitterhttps://t.co/VtGtX0S0eN pic.twitter.com/VaDkA49tBD
A cheaper option that may work Aztreonam/amoxillin-clavulanate!
— Antibiotic Steward (@ABsteward) March 16, 2019
In this new study in AAC: Aztreonam susceptibility was fully restored for 50% of the MBL-producing Enterobacteriaceae when combined with amoxicillin-clavulanate. Interesting! @ASMicrobiology https://t.co/TDEVz3KPVy pic.twitter.com/Kfr20fTKCo
NEW🔥🔥 by @TrubianoJason @BSACandJAC
— Antibiotic Steward (@ABsteward) March 14, 2019
Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention. #IDTwitter #JACnews #IDMedEd. Impressive results 👇 https://t.co/i36GzI1wCq pic.twitter.com/FVFSZlB3XS
NEW🔥 in OFID @stoverkr/ @klusardi41/ @BBookstaver_USC and @blandman19
— Antibiotic Steward (@ABsteward) March 26, 2019
Baker’s Dozen of Top Antimicrobial Stewardship Intervention Publications in 2017. https://t.co/q8Rho7u6DL pic.twitter.com/r1BTXQRm7a
NEW 🔥 in @ICHEJournal @KimberlyBlumen1 @ericashenoy @dberkpharmd
— Antibiotic Steward (@ABsteward) March 27, 2019
An antimicrobial stewardship intervention consisting of β-lactam test-dose challenge procedure was safe. Overall, 3.8% of patients with β-lactam allergy histories had an HSR. #IDTwitter https://t.co/IXn6rvaOlV pic.twitter.com/sfmRbq64dn
NEW 🔥🔥 Systematic review and meta-analysis in #CMI @ASPphysician @Guru_JoshD Cefazolin Vs. anti-staphylococcal penicillins for the treatment of patients with MSSA bacteremia.
— Antibiotic Steward (@ABsteward) March 28, 2019
Read full article 👇#IDTwitter #IDMedEd #CLOCEBA https://t.co/EXldHDn5CA pic.twitter.com/oDYO3E0FIH
NEW 🔥🔥Review Article in CID By Dr. Tamma /Simner
— Antibiotic Steward (@ABsteward) March 6, 2019
Primer on AmpC Beta-Lactamases: Necessary Knowledge for an Increasingly Multidrug-Resistant World. #antibioticsteward https://t.co/JnW7HonF7Y pic.twitter.com/34Ber5ufj6
💊💊💊 ➡️ 🛡🦠🛡
— Bug Pharmacist (@IDstewardship) March 28, 2019
In case you need more reason to try to reduce #antibiotic exposure in ICUs.
👉 https://t.co/Ip4bPjk05n via @ACCP @JACCPJournal @PharmacoJournal #AntibioticTimeout #SaveABX #IDtwitter pic.twitter.com/28cM1cSGtG
In Case You Missed It!
— Antibiotic Steward (@ABsteward) March 15, 2019
New 🔥🔥review article by Dr. Karen Bush & @bradfop1 @NatureRevMicro
Interplay between β-lactamases and new β-lactamase inhibitors. #IDTwitter #IDMedEd #antibioticsteward https://t.co/TOHxgUwooghttps://t.co/TOHxgUwoog pic.twitter.com/gJIfRhydh2
NEW🔥🔥 Review Article in @ASMicrobiology by Dr. Lodise/Drusano/Bhavnani
— Antibiotic Steward (@ABsteward) March 4, 2019
Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents. A must read article #antibioticsteward https://t.co/grIaUtwl4c pic.twitter.com/xfaHaorXKr
ICYMI NEW 🔥 Study in AAC @ASMicrobiology to determine synergism and optimal intravenous dosing regimens of fosfomycin with meropenem against MDR and MBL-producing P. aeruginosa. #pkpd read the full article. ENJOY! https://t.co/4bpxbLP9aS pic.twitter.com/gMha0oOBKV
— Antibiotic Steward (@ABsteward) March 29, 2019
NEW 🔥🔥from the author of @IDSAInfo #CDI Guidelines Dr. McDonald in CID :Association between Antibiotic Use and Hospital-Onset Clostridioides difficile Infection in U.S. Acute Care Hospitals, 2006-2012: an Ecologic Analysis. #antibioticsteward https://t.co/XHcE0ktMno pic.twitter.com/99EFjggbAC
— Antibiotic Steward (@ABsteward) March 1, 2019
NEW 🔥 in CID
— Antibiotic Steward (@ABsteward) March 19, 2019
Short-course(median 9d) therapy had a similar odds of recurrent infection/death within 30 d as those receiving longer course(median 16d) for pseudomonas aeruginosa BSI. How Long is Long Enough? 🤔 @SIDPharm @accpinfdprn @BradSpellberg https://t.co/dR3RPIVGA8 pic.twitter.com/91Ym7spTV4
‼️More Than 2,000 People Held By Immigration & Customs Enforcement Are Being Quarantined Due To An Outbreak Of Mumps & Other Diseases‼️
— Dustie (@DustieDahl) March 14, 2019
‼️Thousands In ICE Custody Quarantined For Infectious Diseases - https://t.co/um423xUBXW
NEW 🔥 in @JACCPJournal @ClaeysKcclaeys @emilylheil Pharmacists’ Perceptions of Implementing AUC Time Curve‐Guided Vancomycin Dosing Program at a Large Academic Medical Center. #IDTwitter #IDMedEd #antibioticsteward https://t.co/SmDdhAELnX pic.twitter.com/TlrUAK04dW
— Antibiotic Steward (@ABsteward) March 11, 2019
NEW🔥 @ASMicrobiology Clinical Data on Daptomycin Plus Ceftaroline Vs Standard of Care Monotherapy in the Treatment of MRSA Bacteremia.Debate Combination therapy with beta-lactam for MRSA bacteremia continues.Awaiting CAMERA 2 #ECCMID2019https://t.co/aJVFAFpMwJ pic.twitter.com/FcBLbn5ehF
— Antibiotic Steward (@ABsteward) March 11, 2019
NEW 🔥review article by @jasonroberts_pk in IJAA Multidrug-resistant Acinetobacter baumannii infections: current evidence on treatment options and role of PK/PD in dose optimizationhttps://t.co/k2qSGBoZEM pic.twitter.com/KDPyrKIuPA
— Antibiotic Steward (@ABsteward) March 2, 2019
In Case You Missed It!
— Antibiotic Steward (@ABsteward) March 20, 2019
New 🔥 in #IJAA
Post- MERINO trial: Any role for piperacillin-tazobactam in treating bloodstream infections caused by ESBL producing Enterobacteriaceae?#MERINO #IDtwitter #IDMedEd https://t.co/94TgORcpKN pic.twitter.com/Q2lN2FIywJ
NEW🔥 data in @TheLancetInfDis suggest that ⬆️ use of fluoroquinolones antibiotics in the neighborhood is associated with an ⬆️ personal risk of acquiring antibiotic-resistant bacteria, independent of personal history of antibiotic consumption. https://t.co/UgtBCkvic5 pic.twitter.com/KUgazyqCUO
— Antibiotic Steward (@ABsteward) March 5, 2019
Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals https://t.co/WXfL2IlfZx #ThreeRiversASP2019
— Julie Szymczak (@JulieSzymczak) March 9, 2019
A NEW🔥 RCT 🇻🇳 @BNadjm MALDITOF-MS, in the absence of an ASP, did NOT improve the proportion on optimal antimicrobial therapy at 24 or 48 hours after 1st growth in a LMIC setting with high rates of antibiotic resistance.
— Antibiotic Steward (@ABsteward) March 24, 2019
RDT + ASP is better. Cc @manfordou https://t.co/Vk6HMWpd9R pic.twitter.com/0FjRm5RJ4y
In IJAA :
— Antibiotic Steward (@ABsteward) March 17, 2019
Ciprofloxacin had the greatest co-selective potential, significantly enriching for resistance mechanisms to multiple antibiotic classes.
You still need more reasons to hate fluoroquinolones?! https://t.co/ARkgzOQ5A7 pic.twitter.com/5s708mkGMP
Tackling antimicrobial resistance is not just about new drugs, it's also about new approaches. Antibiotic stewardship, vaccines and diagnostics are key areas needing more research. Here's how the NIHR is supporting research on #AMR https://t.co/mhQ7fuCl7o #TacklingAMR #EconAMR pic.twitter.com/d3DC4NXooW
— NIHR CRN (@NIHRCRN) March 26, 2019
NEW 🔥 in @AJICJournal : LESS IS MORE : Antipseudomonal combination therapy has a higher mortality rate than monotherapy in adults with community-onset pneumonia. Read full article. #IDTwitter https://t.co/UDXyrAf0Vh pic.twitter.com/2ADjQENJma
— Antibiotic Steward (@ABsteward) March 22, 2019
New!!!
— Bug Pharmacist (@IDstewardship) March 17, 2019
Thinking about 🧠💊 antimicrobial stewardship using 🔬🧫 microbiology lab data...
👉 https://t.co/dWWuMXMzDY #IDtwitter pic.twitter.com/NsaFwBeSiU
Vaccination was being used by trolls and sophisticated bots as a "wedge issue", said Mark Dredze from Johns Hopkins University.
— Jay McKenzie (@JamesFourM) March 10, 2019
"By playing both sides, they erode public trust in vaccination, exposing us all to the risk of infectious diseases," he said.https://t.co/FV5cev0DpQ
This wor(l)d map indicates the reported cases of #infectiousdiseases by continent. Word size represents number of cases. I am dumbstruck even thinking about the Measles comeback...
— Simon Kuestenmacher (@simongerman600) March 2, 2019
Source: https://t.co/q7K13Tn5LX
HT: @scottjbecker pic.twitter.com/Fpmpvyncat
Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance @TuftsCIMAR @IDSAInfo @Wellcome_AMR @CARB_X @SGottliebFDA @Stop_Superbugs @saveantibiotics https://t.co/YKswFg8Tnm
— Helen Boucher (@hboucher3) March 3, 2019
Excellent @marcboten post: impact antibiotic timing to prevent BSI when treating UTI. Could this be the underlying reason for the increase in E. coli BSI in England? An unintended consequence of well-meaning antibiotic stewardship initiatives? https://t.co/qjMz17y8j6
— Jon Otter (@jonotter) March 8, 2019
60 to 70% of average penicillin “allergic” individuals can be safely delabeled with a direct oral amoxicillin challenge. @WalterReedArmy @KPSanDiego
— Eric Macy (@EricMacyMD) March 26, 2019
Evaluating Penicillin Allergies Without Skin Testing. - PubMed - NCBI https://t.co/05KJpoDezr
More positive news from the border👿Sure @SpeakerPelosi let them all in! https://t.co/rQtoo012At
— 🌶 PepperTrumper (K) ⭐️⭐️⭐️ (@peppertrumper) March 14, 2019
Truly global! Our FREE e-Book on #antimicrobial #stewardship has been downloaded by many thousands across the world. This week: France 🇫🇷, Ghana 🇬🇭, UK 🇬🇧, Mexico 🇲🇽, Portugal 🇵🇹, South Korea 🇰🇷. Why not join them? Register here https://t.co/Mz5g3oSwTp pic.twitter.com/kyygmkc8nU
— Antibiotic Action (@TheUrgentNeed) March 13, 2019
New @JClinMicro minireview: genome-based prediction of bacterial antibiotic resistance https://t.co/ZwG8J0WrQT #ASMClinMicro pic.twitter.com/RqgKjazN31
— ASM (@ASMicrobiology) March 18, 2019
This new 🔥 PK study found >2 folds increases in AUC of dexamethasone & methylprednisolone after giving voriconazole. So, authors recommended dose reductions of CS. Would reduce their dose by half in your practice?https://t.co/duKXGvWusK pic.twitter.com/QD63jPzScU
— Antibiotic Tweets (@khalideljaaly) March 8, 2019
New Reflections post on fantastic intervention RCT (REACH study) published in @TheLancetInfDis by @1healthau et al. A simple, low-cost intervention to improve the quality of cleaning reduces VRE infections but not S. aureus BSI or C. difficile infections https://t.co/wx8CI4xx9l
— Jon Otter (@jonotter) March 11, 2019
We have just published the key outcomes from the second Call to Action on Antimicrobial Resistance held last year in Ghana, co-hosted by the Governments of 🇬🇭, 🇹🇭 and 🇬🇧, along with the @WorldBank , @unfoundation and @wellcometrust
— AMR at Wellcome (@Wellcome_AMR) March 11, 2019
Read it here ➡️https://t.co/gVpNHaFIw1 pic.twitter.com/b6YgUttvN0
“7 is the new 14” -SIDP member @ChristianCho reviews the evidence for duration of antibiotic therapy in uncomplicated Gram-negative bacteremia. #AntibioticStewardship @Contagion_Live https://t.co/ImRBUO2j4N
— SIDP (@SIDPharm) March 1, 2019
NEW 🔥in @TheLancetInfDis
— Antibiotic Steward (@ABsteward) March 16, 2019
A new β-lactamase Ribaxamase that degrade excess antibiotics in the upper GI before they disrupt the gut microbiome reduced the incidence of CDI Vs placebo in patients treated with IV β-lactam antibiotics,Interesting concept! https://t.co/c1mufWF1MI pic.twitter.com/ssK4GWOA3o
Between 1950s and 2000, Venezuela showed one of the most substantial improvements in infant mortality rates in Latin America. However, the recent economic crisis alongside an increase in infectious and parasitic diseases might be reversing these patterns. https://t.co/Ue5gIg6Rit
— Moisés Naím (@MoisesNaim) March 2, 2019
NEW🔥 In #CMI
— Antibiotic Steward (@ABsteward) March 23, 2019
Applying EUCAST instead of CLSI breakpoints to E. coli, K. pneumoniae & P. aeruginosa isolates would have increased rates of ciprofloxacin resistance (59.1% vs 46.5% in E. coli, 37.5% vs 13.9% in KP, 28.2% vs 10.3% in PSA. #IDTwitter https://t.co/Ghi4qOkA4z pic.twitter.com/yz4ni2lrIV
Yes, culture matters👉🏼 https://t.co/nzqwTpoptp 👉🏼 https://t.co/GcW1xNbcOX 👉🏼 WHO/Europe | Antimicrobial resistance - Antibiotic resistance: using a cultural contexts of health approach to address a global health challenge (2019) https://t.co/pE8u23t7Sq
— Esmita Charani (@e_charani) March 3, 2019
The word "microbiome" and the idea of complex microbial ecosystems is not new. In a new Microbial Sciences article, we review the contributions of Sergei Winogradsky and the origins of microbial ecology: https://t.co/XQ1EKAgahJ
— ASM (@ASMicrobiology) March 10, 2019
“Long term care facilities account for significant antibiotic use but have weaker antibiotic stewardship and infection control than hospitals.” David Livermore, Prof of Medical Microbiology @uniofeastanglia on reducing antibiotics in long-term care homes.https://t.co/9I0FOaiE5t
— NIHR Dissemination (@NIHR_DC) March 17, 2019
Eek! So thrilled that my @sciam feature "American Epidemic," on how economics and infrastructure drive the spread of infectious diseases in the U.S., has won a 2nd place award in the @AHCJ Awards for Excellence in Health Care Journalism! https://t.co/iT5923UOwf
— Melinda Wenner Moyer (@lindy2350) March 27, 2019
New in #ClinInfectDis: Updated guidelines for asymptomatic bacteriuria (ASB) add infants and children, people who have had non-urologic surgery and organ transplants to the populations that shouldn’t be screened for UTIs unless experiencing other symptoms. https://t.co/C7SP7zqXIs pic.twitter.com/btFffdSluN
— IDSA (@IDSAInfo) March 21, 2019
Globe editorial: Why humans ignore the slow-motion catastrophes all around them. Relevant to #AntimicrobialResistance https://t.co/YB77p92fYj
— Andrew Morris (@ASPphysician) March 28, 2019
Antimicrobial stewardship | What They Don’t Teach You At Medical School
— Luke Moore 🇪🇺🇬🇧🇦🇺 (@dr_luke_moore) March 21, 2019
| British Journal of Hospital Medicine https://t.co/TK7OnH0S0x#AMS #AMR #MedEd #BJHM@StephenJ_Hughes @ChelwestRD @HPRUamr @BRCinfection @ARC_at_Imperial @bjhospmed
Antimicrobial Resistance worsens an already high burden of Infectious Diseases in LMICs.
— Otto Cars (@OttoCars1) March 19, 2019
Read the report on AMR as a Global Development Problem https://t.co/RTk04ohEVf
#AMR #SDGs #GlobalGoals pic.twitter.com/m2U2Jl3PYZ
Syndrome-specific #antimicrobialstewardship interventions associated with reduced fluoroquinolone use and improved Pseudomonas susceptibility https://t.co/yPN0hCwLgw via @AJICJournal
— Brad Langford (@BRxAD) March 9, 2019
Drug-resistant infections could kill more people than cancer by 2050.
— Carlos Moedas (@Moedas) March 31, 2019
Antibiotics are becoming less effective for treating infectious diseases.
Have a look at the levels of resistance to antibiotics in your country with @EFSA_EU tool. #AMR #OneHealth https://t.co/6zNivKw4mt
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.